Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions
Meibomian Gland DysfunctionBlepharitisDoxycycline Adverse Reaction
Interventions
DRUG

Doxycyclin

The drug has been prescribed, as in normal clinical practice, with the National Healthcare System. Patients have been fully informed about interactions, toxicity and posology schedule.

Trial Locations (1)

20142

ASST Santi Paolo e Carlo - Ospedale San Paolo, Milan

All Listed Sponsors
lead

University of Milan

OTHER